Faulty proteins may prove significant in identifying new treatments for ovarian cancer
OHSU Knight Cancer Institute study results suggest that more patients than initially thought could potentially be treated with a new class of drugs, PARP inhibitors
2012-01-16
(Press-News.org) PORTLAND, Ore. -- A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range of ovarian cancer patients, an Oregon Health & Science University Knight Cancer Institute study found.
These research results, published this week in PLoS ONE, have prompted additional exploration into whether the patient population included in clinical trials for drugs that target the enzyme poly ADP ribose polymerase (PARP) should be expanded. Several forms of cancer are more dependent on PARP for their growth than regular cells, which means that targeting these enzymes when they go haywire is a potentially effective way to treat ovarian cancer. Currently PARP inhibitors are being tested with patients who have two types of malfunctioning proteins, BRCA1 or BRCA2. But, the OHSU Knight Cancer Institute study of additional proteins, beyond BRCA proteins, suggests that they too are playing a role in driving ovarian cancer.
Tapping into the potential of PARP inhibitors could change the dynamics of ovarian cancer treatment. There has not been a substantial increase in treatment options for ovarian cancer in the past two decades, said Tanja Pejovic, M.D., Ph.D., gynecologic oncologist at the OHSU Knight Cancer Institute. Pejovic, who led the study of these additional defective proteins, added that the results provide evidence that further research into the role of multiple proteins is warranted.
Only about 10 to 15 percent of women with ovarian cancer have BRCA 1 or BRCA 2 mutations.
Pejovic's study of 186 patients with nonhereditary cancer found that 41 percent who had an early recurrence of the disease also had abnormal levels of the other proteins tracked. In contrast, only 19.5 percent of patients who hadn't yet had a recurrence of the disease in three years had abnormal levels of these proteins.
"If we are able to identify the proteins that differentiate these patients at risk for early recurrence, this would open up a new direction in ovarian cancer treatment," Pejovic said.
###
The study — which was supported by the Sherie Hildreth Ovarian Cancer (SHOC) Foundation — focused on proteins that are supposed to assist cells in repairing harmful breaks in DNA strands, a process called homologous recombination (HR). The malfunctioning of HR is not well understood in ovarian cancers where there is no family history of the disease. However, there is evidence that these proteins influence a patient's ability to respond to drugs and their survival rates after treatment.
Ovarian cancer is the second most common gynecologic cancer and the most common cause of death among women with a gynecologic cancer. About 21,000 ovarian cancer cases are diagnosed annually and about 14,000 deaths occur each year from the disease.
The OHSU Knight Cancer Institute, which helped pioneer the field of personalized cancer medicine, is committed to research that identifies the specific mutations driving each individual patient's cancer. Other researchers at the Knight Cancer Institute who contributed to the study are: Weiya Z. Wysham, M.D.; Hong Li, M.S., M.D.; Laura Hays, Ph.D.; Jay Wright; Nupur Pande, Ph.D.; and Maureen Hoatlin, Ph.D.
ELSE PRESS RELEASES FROM THIS DATE:
2012-01-16
MBL, WOODS HOLE, MA -- Just like people, some proteins have characteristic ways of "walking," which (also like human gaits) are not so easy to describe. But now scientists have discovered the unique "drunken sailor" gait of dynein, a protein that is critical for the function of every cell in the body and whose malfunction has been associated with neurodegenerative disorders such as Lou Gehrig's disease and Parkinson's disease.
The research, which was led by Samara Reck-Peterson of Harvard Medical School and partially conducted in the MBL Physiology Course, received advance ...
2012-01-16
In the highly competitive commercial marine industry, employers must find a way to recruit, retain and compensate employees. What are the best strategies, training, and research that can be utilized to meet the demands of a growing industry? What makes industry employees happy, productive and loyal?
Maritime employee recruitment, retention and compensation will be the topic of the WorkBoat.com webinar on Wednesday, Jan. 25, at 1 p.m. (eastern).
To register for the webinar, visit www.WorkBoat.com. Cost to attend the webinar is $59. Individuals can also purchase the ...
2012-01-16
With an eye on rapid changes in the resource-rich Arctic, countries like China, India and Brazil, which have no Arctic territories, are nonetheless knocking on the door of the increasingly influential Arctic Council looking for admission as permanent observers.
The issue has divided existing members, with Russia and Canada most strongly opposed. It is among the major questions with which Canada will have to grapple as it prepares to chair the Council next year.
It will also feature prominently on the agenda of a two-day meeting on the future of the Arctic Council, January ...
2012-01-16
Massachusetts General Hospital (MGH) investigators have developed a novel strategy to protect the liver from drug-induced injury and improve associated drug safety. In their report receiving advance online publication in the journal Nature Biotechnology, the team reports that inhibition of a type of cell-to-cell communication can protect against the damage caused by liver-toxic drugs such as acetaminophen.
"Our findings suggest that this therapy could be a clinically viable strategy for treating patients with drug-induced liver injury," says Suraj Patel, PhD, of the ...
2012-01-16
Hundreds of times during a baseball game, the home plate umpire must instantaneously categorize a fast-moving pitch as a ball or a strike. In new research from the University of Chicago, scientists have pinpointed an area in the brain where these kinds of visual categories are encoded.
While monkeys played a computer game in which they had to quickly determine the category of a moving visual stimulus, neural recordings revealed brain activity that encoded those categories. Surprisingly, a region of the brain known as the posterior parietal cortex demonstrated faster and ...
2012-01-16
A team of four British engineers has returned to the UK after completing a gruelling journey to one of the most remote and hostile locations on the planet to put in place equipment and supplies for an ambitious project later this year. Enduring temperatures of minus 35°C the Subglacial Lake Ellsworth 'Advance Party' has successfully paved the way to explore an ancient lake buried beneath 3 km of Antarctic ice. A powerful 'tractor-train' towed nearly 70 tonnes of equipment across Antarctica's ice over deep snow and steep mountain passes. In December a science and engineering ...
2012-01-16
The problem is the sheer number: In the family tree of modern-day corn, there are two main groups with 10,000 pure-breed lines each. Each of these lines could potentially be used for producing a new variety by means of cross-breeding. In mathematical terms, that equates to 100 billion possibilities. In terms of corn, however, a parent's performance is no indicator of what potential lies hidden in their offspring. Even the feeblest of parents can produce mighty offspring when cross-bred.
But time is of essence: Currently it takes approximately 10 years for breeders to ...
2012-01-16
Scientists working at the Medical Research Council have identified changes in the patterns of sugar molecules that line pre-cancerous cells in the esophagus, a condition called Barrett's dysplasia, making it much easier to detect and remove these cells before they develop into esophageal cancer. These findings, reported in the journal Nature Medicine, have important implications for patients and may help to monitor their condition and prevent the development of cancer.
Oesophageal cancer is the fifth biggest cause of cancer death in the United Kingdom and the eighth leading ...
2012-01-16
Killer T-cells in the human body which help protect us from disease can inadvertently destroy cells that produce insulin, new research has uncovered.
The study provides the first evidence of this mechanism in action and could offer new understanding of the cause of Type 1 diabetes.
Professor Andy Sewell, an expert in human T-cells from Cardiff University's School of Medicine worked alongside diabetes experts from King's College London to better understand the role of T-cells in the development of Type 1 diabetes.
The team isolated a T-cell from a patient with Type ...
2012-01-16
Telomeres, the very ends of chromosomes, become shorter as we age. When a cell divides it first duplicates its DNA and, because the DNA replication machinery fails to get all the way to the end, with each successive cell division a little bit more is missed. New research published in BioMed Central's open access journal Arthritis Research & Therapy shows that cells from osteoarthritic knees have abnormally shortened telomeres and that the percentage of cells with ultra short telomeres increases the closer to the damaged region within the joint.
While the shortening of ...
LAST 30 PRESS RELEASES:
[Press-News.org] Faulty proteins may prove significant in identifying new treatments for ovarian cancer
OHSU Knight Cancer Institute study results suggest that more patients than initially thought could potentially be treated with a new class of drugs, PARP inhibitors
